tci Part B Insider - 2014 Issue 40

Reader Question: Avoid 90662 for Patients Under 65

Question: We reported 90662 for a patient’s Fluzone shot and it was denied. The insurer said the patient doesn’t meet the age requirements, but we didn’t see any age listed on the code descriptor. Can you advise? Answer: Most MACs will only cover 90662 (Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use) for patients age 65 and older. The higher antigen content offers increased protection to older patients, and this code is considered a high dosage of the Fluzone vaccine because it contains four times the hemagglutinin antigen...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.